Likewise, the use of GLP-1 receptor antagonists not only blocks GLP-1 but also any potential action of glucagon on GLP-1 receptors
Phase II clinical trials of this inhibitor have been completed for patients with ovarian cancer and myelodysplastic syndrome (NCT01822691, NCT01685255)
However, current American Diabetes Association (ADA) and American College of Cardiology/American Heart Association (ACC/AHA) guidelines no longer routinely recommend niacin for cardiovascular risk reduction due to lack of demonstrated outcome benefits and potential adverse effects
Pharmaceuticals , 18(2), 185
PMID: 40 DuanXWangHHoDDSchwartzREEvansTChenS
Studies on human sleep behavior and chronic insomniac patients reveal that the peptide improves sleep architecture and sleep structure by promoting slow-wave (delta) sleep and supporting restorative, non-REM sleep (1)